Clovis Oncology
CLVS
#10290
Rank
โ‚น1.06 B
Marketcap
โ‚น7.33
Share price
0.00%
Change (1 day)
-94.79%
Change (1 year)

EPS for Clovis Oncology (CLVS)

EPS in 2022 (TTM): -โ‚น146.21

According to Clovis Oncology's latest financial reports the company's current EPS (TTM) is -โ‚น170.50. In 2012 the company made an earnings per share (EPS) of -โ‚น269.74.

EPS history for Clovis Oncology from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-โ‚น146.21
2012-โ‚น269.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioMarin Pharmaceutical
BMRN
โ‚น245.38-243.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น273.79-260.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚น155.17-191.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น941.76-652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น121.95-171.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,851-1,185.63%๐Ÿ‡บ๐Ÿ‡ธ USA